Table 1.
Demographic Characteristics of Schizophrenic Patients (SZ) and Healthy Control Subjects, n=154
| Characteristic n |
SZ n=64 |
Control n=90 |
Proba |
|---|---|---|---|
| Females, % (n) | 51.6 (33) | 51.1 (46) | .9560 |
| Ethnicity, % (n) | .9775 | ||
| African American | 32.8 (21) | 34.4 (31) | |
| Caucasian | 34.4 (22) | 33.3 (30) | |
| Hispanic | 32.8 (21) | 32.2 (29) | |
| Age (years), mean ± SD | 38.5 ± 11.3 | 37.9 ± 12.0 | .7187 |
| Body Mass Index, mean ± SD | 27.2 ± 5.4 | 26.4 ± 5.0 | .3663 |
| Smoking Status, % (n) | <.0001* | ||
| Current or Previous | 60.93 (39) | 24.4 (22) | |
| Never Smoked | 34.38 (22) | 74.5 (67) | |
| Not reported | 4.69 (3) | 1.1 (1) | |
| History of Alcoholism, % (n) | .7087 | ||
| Abuse | 9.4 (6) | 6.7 (6) | |
| Dependence | 6.3 (4) | 4.4 (4) | |
| Neither | 84.4 (54) | 88.9 (80) | |
| History of Substance Abuse, % (n) | .1279 | ||
| Abuse | 7.8 (5) | 3.3 (3) | |
| Dependence | 14.1 (9) | 6.7 (6) | |
| Neither | 78.1 (50) | 90.0 (81) | |
| History of Seizures, % (n) | 1.6 (1) | 0 (0) | .4106 |
| Asthma, % (n) | 7.9 (5) | 9.0 (8) | .7368 |
| IDD, % (n)b | 4.8 (3) | 0 (0) | .0692 |
| NIDD, % (n)c | 7.9 (5) | 4.4 (4) | .4855 |
| Common Medication, % (n) | |||
| Antibiotics | 3.1 (2) | 0 (0) | .1711 |
| Antilipidemics | 6.3 (4) | 4.4 (4) | .7192 |
| Antihypertensives | 9.4 (6) | 3.3 (3) | .1644 |
| Antivirals | 1.6 (1) | 1.1 (1) | .9999 |
| Steroids | 6.3 (4) | 1.1 (1) | .1609 |
a
p-values calculated by Satterthwaite t-test, Fisher exact test, or Chi-Square
*
=significant values when comparing SZ patients to controls.
b
IDD = Insulin Dependent Diabetes
c
NIDD = Non-Insulin Dependent Diabetes